The Pharmacokinetics and Bioequivalence of Desvenlafaxine Succinate in Chinese Healthy Subjects Under Fasting and Fed States.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical pharmacology in drug development"
DOI: 10.1002/cpdd.1272
Abstract: Desvenlafaxine succinate is a selective serotonin-norepinephrine reuptake inhibitor for the treatment of major depressive disorder. The pharmacokinetic profile of desvenlafaxine succinate at the clinically recommended dose of 50 mg in Chinese healthy subjects has been reported… read more here.
Keywords: fasting fed; desvenlafaxine succinate; pharmacokinetics bioequivalence; chinese healthy ... See more keywords
A Multi-layered Particulate System for Desvenlafaxine Succinate Oral Customized Release.
Sign Up to like & getrecommendations! Published in 2017 at "Current drug delivery"
DOI: 10.2174/1567201813666160523143111
Abstract: BACKGROUND With its reported side effects Desvenlafaxine succinate (DSV) is a good candidate to prepare prolonged release system. Such prolonged release could decrease the rapid DSV absorption after oral administration and reduce its exaggerated side… read more here.
Keywords: side effects; system; release; dsv ... See more keywords